Cargando…
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
The REMARK “elaboration and explanation” guideline, by Doug Altman and colleagues, provides a detailed reference for authors on important issues to consider when designing, conducting, and analyzing tumor marker prognostic studies.
Autores principales: | Altman, Douglas G., McShane, Lisa M., Sauerbrei, Willi, Taube, Sheila E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362085/ https://www.ncbi.nlm.nih.gov/pubmed/22675273 http://dx.doi.org/10.1371/journal.pmed.1001216 |
Ejemplares similares
-
Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration
por: Altman, Douglas G, et al.
Publicado: (2012) -
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An
Abridged Explanation and Elaboration
por: Sauerbrei, Willi, et al.
Publicado: (2018) -
REporting recommendations for tumour MARKer prognostic studies (REMARK)
por: McShane, L M, et al.
Publicado: (2005) -
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
por: Liberati, Alessandro, et al.
Publicado: (2009) -
Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
por: Hanekom, Willem A, et al.
Publicado: (2008)